Total Revenues in the first nine months of 2024 increased by $300 million compared to same period in 2023, to $339 million, with Q3 revenues contributing $103 millionProduct revenues in the first nine ...
Inovio Pharmaceuticals ( INO -3.64%) Q3 2024 Earnings Call Nov 14, 2024, 4:30 p.m. ET ...
Daré Bioscience, Inc. ( NASDAQ: DARE) Q3 2024 Earnings Conference Call November 14, 2024 4:30 PM ET MarDee Haring-Layton - CAO Sabrina Martucci Johnson - President and CEO ...
BioCardia (BCDA – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Joseph Pantginis ...
Zacks.com on MSN11h
Biotech Stock Roundup: NVAX Q3 Results, SNDX Down on AML Data, RNA Surges on Study DataAs the third-quarter earnings season ends this week, the focus in the biotech sector is mostly on pipeline and key regulatory ...
In a report released yesterday, Tate Sullivan from Maxim Group maintained a Buy rating on Altus Power (AMPS – Research Report), with a ...
Q3 2024 Earnings Call Transcript November 13, 2024 Operator: Greetings, and welcome to the Acurx Pharmaceuticals, Inc. Third ...
The Dragon Quest games have hewed to tradition over the past four decades. Series creator Yuji Horii, inspired by Ultima and ...
French reinsurer SCOR has reported a group net loss of €-117 million in Q3 2024, driven by a negative insurance service ...
Leasing volume for non-landed residential property in Q3 rose 24.4% QoQ) to 25,731 amidst the school year and corporate ...
Peraso expressly disclaims any obligation to update or alter its forward-looking statements, whether as a result of new ...
Q3 2024 ReportResults in line for Q3 2024 with sales momentum increasing throughout the period and into Q4GIG Software Plc ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback